CF
COEPW

Cantor Fitzgerald’s Coeptis Therapeutics Warrants COEPW Stock Holding History

Cantor Fitzgerald’s Portfolio COEPW Stock Details COEPW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-106,459
Closed -$3.07K – 411
2025
Q2 		$3.07K Hold
106,459
– – ﹤0.01% 442
2025
Q1 		$1.15K Hold
106,459
– – ﹤0.01% 315
2024
Q4 		$1.07K Hold
106,459
– – ﹤0.01% 273
2024
Q3 		$1.6K Hold
106,459
– – ﹤0.01% 210
2024
Q2 		$12.8K Hold
106,459
– – ﹤0.01% 214
2024
Q1 		$12.8K Hold
106,459
– – ﹤0.01% 221
2023
Q4 		$12.8K Hold
106,459
– – ﹤0.01% 199
2023
Q3 		$12.8K Hold
106,459
– – ﹤0.01% 506
2023
Q2 		$12.8K Hold
106,459
– – ﹤0.01% 522
2023
Q1 		$12.8K Buy
+106,459
New +$13.7K ﹤0.01% 619
2022
Q4 		– Sell
-106,459
Closed -$3K – 726
2022
Q3 		$3K Hold
106,459
– – ﹤0.01% 756
2022
Q2 		$4K Hold
106,459
– – ﹤0.01% 804
2022
Q1 		$9K Hold
106,459
– – ﹤0.01% 397
2021
Q4 		$34K Buy
+106,459
New +$35.4K ﹤0.01% 360

Other funds holding COEPW

RCM
Rivernorth Capital Management West Palm Beach, Florida $2.1B AUM 2.15% 1-Year Est. Return
MC
Meteora Capital Boca Raton, Florida $1.21B AUM 13.69% 1-Year Est. Return
Walleye Trading
Walleye Trading New York $87.6B AUM 68.17% 1-Year Est. Return
CL
CSS LLC Chicago, Illinois $2.57B AUM 67.1% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return
SIA
SkyView Investment Advisors Shrewsbury, New Jersey $128M AUM 19.21% 1-Year Est. Return
LCM
Landscape Capital Management Englewood, New Jersey $1.54B AUM 30.95% 1-Year Est. Return
HHGC
Hunting Hill Global Capital New York $129M AUM 17.34% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
CS
Clear Street New York $39.5B AUM 124.03% 1-Year Est. Return

Cantor Fitzgerald's COEPW Position: Q3 2025 in Review

Cantor Fitzgerald sold out of Coeptis Therapeutics Warrants (COEPW) in Q3 2025, closing a stake of 106,459 shares — an estimated $3.07K sold.

Cantor Fitzgerald first reported a position in COEPW in Q4 2021 and held it in 14 quarters. The position peaked at $34K in Q4 2021. 11 funds tracked by Wall St. Rank hold COEPW as of Q3 2025.

  • Cantor Fitzgerald reported no remaining Coeptis Therapeutics Warrants position as of Q3 2025 after selling out during the quarter.
  • Cantor Fitzgerald sold 106,459 Coeptis Therapeutics Warrants shares in Q3 2025, an estimated $3.07K.
  • Cantor Fitzgerald first reported a position in Coeptis Therapeutics Warrants in Q4 2021 and held it in 14 quarters.
  • Cantor Fitzgerald's Coeptis Therapeutics Warrants position peaked at $34K in Q4 2021.
  • 11 funds tracked by Wall St. Rank held Coeptis Therapeutics Warrants as of Q3 2025.

Based on Cantor Fitzgerald's 13F filing for Q3 2025, filed 14 Nov 2025.